Dal Bello, S.; Lorenzut, S.; Saccomano, E.; Tereshko, Y.; Gigli, G.L.; Pucillo, C.E.; Valente, M.
NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy. Pharmaceuticals 2024, 17, 150.
https://doi.org/10.3390/ph17020150
AMA Style
Dal Bello S, Lorenzut S, Saccomano E, Tereshko Y, Gigli GL, Pucillo CE, Valente M.
NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy. Pharmaceuticals. 2024; 17(2):150.
https://doi.org/10.3390/ph17020150
Chicago/Turabian Style
Dal Bello, Simone, Simone Lorenzut, Emma Saccomano, Yan Tereshko, Gian Luigi Gigli, Carlo Ennio Pucillo, and Mariarosaria Valente.
2024. "NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy" Pharmaceuticals 17, no. 2: 150.
https://doi.org/10.3390/ph17020150
APA Style
Dal Bello, S., Lorenzut, S., Saccomano, E., Tereshko, Y., Gigli, G. L., Pucillo, C. E., & Valente, M.
(2024). NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy. Pharmaceuticals, 17(2), 150.
https://doi.org/10.3390/ph17020150